Aristopharma Ltd

Our Products

Aroflo (Salmeterol & Fluticasone Propionate)

Therapeutic Group : Inhaler

Share on facebook
Share on twitter
Share on print
Share on email
Aroflo HFA inhaler is a combination of Salmeterol and Fluticasone Propionate. Salmeterol is a selective, long acting ß2 agonist used in the treatment of asthma and other forms of diffuse airways obstruction. Fluticasone Propionate is corticosteroid with potent anti-inflammatory activity. Fluticasone Propionate is stated to exert a topical effect on the lungs without systemic effects at usual dose.